U2Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2014	FY 2013
Period Ending	Mar '26 Mar 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Market Capitalization	364,854	30,080	59,596	49,318	-	-
Market Cap Growth	1026.29%	-49.53%	20.84%	-	-	-
Enterprise Value	334,906	-3,866	23,197	52,691	-	-
Last Close Price	22900.00	2596.84	5144.96	6286.26	-	-
PE Ratio	-	-	92.27	3.75	-	-
PS Ratio	14.26	1.20	1.94	0.72	-	-
PB Ratio	10.86	0.87	1.57	1.46	-	-
P/TBV Ratio	11.22	0.88	1.58	1.47	-	-
P/FCF Ratio	-	-	-	2.10	-	-
P/OCF Ratio	-	-	-	2.02	-	-
EV/Sales Ratio	13.09	-	0.75	0.76	-	-
EV/EBITDA Ratio	-	-	-	3.18	-	-
EV/EBIT Ratio	-	-	-	3.35	-	-
EV/FCF Ratio	-517.04	-	-	2.25	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	1.13	2.31
Debt / EBITDA Ratio	-	-	-	0.03	4.77	5.73
Debt / FCF Ratio	-	-	-	0.02	-	-
Net Debt / Equity Ratio	-0.89	-0.97	-0.96	-1.08	0.87	2.17
Net Debt / EBITDA Ratio	17.32	16.35	86.70	-2.19	3.68	5.38
Net Debt / FCF Ratio	46.23	18.90	13.12	-1.55	-2.28	-10.28
Asset Turnover	0.56	0.53	0.61	-	1.06	-
Inventory Turnover	23.36	26.49	30.54	-	18.23	-
Quick Ratio	5.92	6.27	5.52	3.22	1.79	1.51
Current Ratio	6.07	6.40	5.64	3.27	1.88	1.64
Return on Equity (ROE)	-8.51%	-7.85%	1.80%	-	9.93%	-
Return on Assets (ROA)	-3.40%	-3.89%	-1.67%	-	4.15%	-
Return on Invested Capital (ROIC)	-110.63%	-229.92%	-	547.93%	11.16%	8.81%
Return on Capital Employed (ROCE)	-6.60%	-7.60%	-3.20%	43.20%	11.10%	11.90%
Earnings Yield	-0.82%	-9.44%	1.08%	26.68%	-	-
FCF Yield	-0.18%	-5.90%	-4.65%	47.53%	-	-
Payout Ratio	-	-	195.50%	5.76%	-	-
Buyback Yield / Dilution	-0.55%	-10.09%	-1.51%	-598.90%	-22.57%	-

Source: S&P Capital IQ. Standard template. Financial Sources.